8 September 2021
Kromek Group plc
("Kromek" or the "Group")
Result of AGM
Kromek (AIM: KMK), a worldwide supplier of detection technology focusing on the medical, security screening and nuclear markets, announces that at its Annual General Meeting ("AGM"), held earlier today, all resolutions were duly passed.
Details of the proxy voting results, which should be read alongside the Notice of AGM, are below:
| Resolution | Votes for* | Votes against | Votes withheld | Total proxy votes | ||
| | No. of votes | % of votes cast** | No. of votes | % of votes cast** | No. of votes | |
| 1 | 133,777,364 | 89.54 | 15,624,010 | 10.46 | 54,217 | 149,455,591 |
| 2 | 147,974,523 | 99.79 | 318,496 | 0.21 | 1,162,572 | 149,455,591 |
| 3 | 148,094,523 | 99.87 | 198,496 | 0.13 | 1,162,572 | 149,455,591 |
| 4 | 147,966,054 | 99.78 | 326,965 | 0.22 | 1,162,572 | 149,455,591 |
| 5 | 140,307,685 | 94.73 | 7,801,643 | 5.27 | 1,346,263 | 149,455,591 |
| 6 | 149,160,289 | 99.87 | 192,048 | 0.13 | 103,254 | 149,455,591 |
| 7 | 146,992,772 | 99.73 | 391,383 | 0.27 | 2,071,436 | 149,455,591 |
| 8 | 142,130,784 | 96.38 | 5,337,678 | 3.62 | 1,987,129 | 149,455,591 |
| 9 | 139,210,426 | 94.39 | 8,268,036 | 5.61 | 1,977,129 | 149,455,591 |
* Includes discretionary votes
** Excludes withheld votes
For further information, please contact:
| Kromek Group plc |
|
| Arnab Basu, CEO Paul Farquhar, CFO
| +44 (0)1740 626 060 |
| Cenkos Securities plc (Nominated Adviser and Broker) |
|
| Camilla Hume/Giles Balleny (NOMAD) Julian Morse (Sales)
| +44 (0)20 7397 8900 |
| Luther Pendragon (PR) |
|
| Harry Chathli, Claire Norbury
| +44 (0)20 7618 9100 |
About Kromek Group plc
Kromek Group plc is a technology group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.
The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.
The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").
The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.
Currently, the Group has over 150 full-time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and https://twitter.com/kromekgroup.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
